Department of Anesthesiology, Guangdong Women and Children Hospital, China.
Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China.
Saudi J Gastroenterol. 2022 Jan-Feb;28(1):54-59. doi: 10.4103/sjg.sjg_275_21.
BACKGROUND: Propofol is commonly used for providing procedural sedation during pediatric colonoscopy. Intravenous (i.v.) lidocaine can mitigate visceral pain and reduce propofol requirements during surgery. The aim of this study is to investigate the effect of i.v. lidocaine on perioperative propofol and sufentanil dose, pulse oxygen saturation, postoperative pain score, and recovery time during pediatric colonoscopy. METHODS: We designed a randomized, double-blind, placebo-controlled study and enrolled 40 children aged from 3 to 10 years who underwent colonoscopy. After titration of propofol to achieve unconsciousness, the patients were given i.v. lidocaine (1.5 mg/kg later 2 mg/kghour) or the same volume of saline. Sedation was standardized and combined propofol with sufentanil. The primary outcome variables were intraoperative propofol and sufentanil requirements, and the number of oxygen desaturation episodes. Secondary outcome variables were recovery time after colonoscopy and post-colonoscopy pain. RESULTS: Lidocaine infusion resulted in a significant reduction in propofol requirements: (median (quartile) 1.8 (1.5-2.0) vs. 3.0 (2.8-3.3) mg/kg respectively; P < 0.001) and sufentanil requirements: (median (quartile) 0.06 (0.05-0.08) vs. 0.1 (0.1-0.1) μg/kg respectively; P < 0.001). The number of subjects who experienced oxygen desaturation below 95% in the lidocaine group was also significantly less than that in the control group: 1 vs. 6 (P = 0.04). The mean (SD) recovery time was significantly shorter in the lidocaine group: (19.2 (2.6) vs. 13.3 (2.6) min respectively; P < 0.001). There was no significant difference in post-colonoscopy pain. CONCLUSION: Continuous infusion of lidocaine resulted in reduction of propofol and sufentanil requirements, recovery time, and risk of hypoxemia during pediatric colonoscopy.
背景:异丙酚常用于小儿结肠镜检查时提供镇静。静脉内(iv)利多卡因可减轻内脏疼痛并减少手术期间异丙酚的需要量。本研究旨在探讨静脉内利多卡因对小儿结肠镜检查期间围手术期异丙酚和舒芬太尼剂量、脉搏血氧饱和度、术后疼痛评分和恢复时间的影响。
方法:我们设计了一项随机、双盲、安慰剂对照研究,纳入了 40 名年龄在 3 至 10 岁之间接受结肠镜检查的儿童。在异丙酚滴定至无意识后,患者给予静脉内利多卡因(1.5mg/kg 后 2mg/kg/h)或相同体积的生理盐水。镇静标准化并与异丙酚和舒芬太尼联合使用。主要结局变量是术中异丙酚和舒芬太尼的需要量和缺氧发作的次数。次要结局变量是结肠镜检查后的恢复时间和结肠镜检查后的疼痛。
结果:利多卡因输注导致异丙酚需求显著减少:(中位数(四分位距)1.8(1.5-2.0)比 3.0(2.8-3.3)mg/kg;P <0.001)和舒芬太尼需求:(中位数(四分位距)0.06(0.05-0.08)比 0.1(0.1-0.1)μg/kg;P <0.001)。利多卡因组发生氧饱和度低于 95%的患者人数也明显少于对照组:1 比 6(P = 0.04)。利多卡因组的平均(标准差)恢复时间明显缩短:(19.2(2.6)比 13.3(2.6)min;P <0.001)。结肠镜检查后疼痛无明显差异。
结论:连续输注利多卡因可减少小儿结肠镜检查期间异丙酚和舒芬太尼的需要量、恢复时间和缺氧风险。
Zhonghua Yi Xue Za Zhi. 2017-3-28
Naunyn Schmiedebergs Arch Pharmacol. 2025-9-4
Saudi J Gastroenterol. 2021
Medicine (Baltimore). 2020-4
J Pediatr Pharmacol Ther. 2019
Cochrane Database Syst Rev. 2018-6-4
Anesthesiology. 2017-4
Z Gastroenterol. 2017-5